| Sign In to gain access to subscriptions and/or personal tools. |
Computerized Cognitive Assessment of Mild Cognitive Impairment in Urban African AmericansDepartment of Clinical Science, NeuroTrax Corporation, Newark, New Jersey, glen.doniger{at}neurotrax.com
Department of Neurology, SUNY Downstate Medical Center, Brooklyn, New York
Department of Clinical Science, NeuroTrax Corporation, Newark, New Jersey, Department of Neurology, Albert Einstein College of Medicine, Bronx, New York
Department of Neurology, SUNY Downstate Medical Center, Brooklyn, New York Few objective cognitive assessment tools have been validated for mild cognitive impairment (MCI) in African Americans despite higher prevalence of disease. This preliminary study evaluated discriminant validity of a computerized cognitive assessment battery for MCI in an urban African American cohort. Twenty-seven participants with MCI and 22 cognitively healthy individuals completed a multidomain battery (Mindstreams, NeuroTrax Corp, New Jersey). Mild cognitive impairment participants performed more poorly than cognitively healthy participants in all domains, with significant differences in memory (P = .003; d = 0.96), executive function (P = .046; d = 0.64), and overall battery performance (P = .041; d = 0.63). Adjustment for intelligence quotient (IQ) yielded significant differences in memory (P < .001; d = 1.34), executive function (P = .007; d = 0.86), attention (P = .014; d = .80), and overall performance (P = .001; d = 1.09). Such a validated battery may help to address an important clinical need in this population.
Key Words: cognitive assessment mild cognitive impairment MCI African American computerized battery
This version was published on October
1, 2009 American Journal of Alzheimer's Disease and Other Dementias®, Vol. 24, No. 5,
396-403 (2009) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||